The role of capicua in spinocerebellar ataxia type 1
The role of capicua in spinocerebellar ataxia type 1
批准号:
7243457
负责人:
John David Fryer
金额:
$4.88万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-01 至 2009-05-31
关键词:
AffectAgeAtaxiaBehavioralBindingBioinformaticsBiologicalBiological AssayBrain StemBreedingCerebellumComplexCoupledDataData SetDevelopmentDiseaseDrosophila genusElectrophoretic Mobility Shift AssayEmbryoEmbryonic DevelopmentFellowshipFunctional disorderGene ExpressionGenerationsGenesGlutamineGoalsImmunofluorescence ImmunologicImmunohistochemistryImmunoprecipitationIndividualKnock-in MouseKnockout MiceLaboratoriesLeadLightLocalizedMammalsMemoryMessenger RNAMicroarray AnalysisModelingMolecularMolecular Sieve ChromatographyMusMutant Strains MiceNamesNerve DegenerationNeurodegenerative DisordersNeuronsOnset of illnessOrthologous GeneOverlapping GenesPathogenesisPathway interactionsPatternPhenotypePhysiologic pulseProtein FamilyProtein OverexpressionProteinsPulse takingPurkinje CellsReverse Transcriptase Polymerase Chain ReactionRoleRunningSpinocerebellar AtaxiasTestingTwo-Hybrid System TechniquesType 1 Spinocerebellar AtaxiaWestern BlottingYeastsataxin-1behavior measurementchromatin immunoprecipitationdisease phenotypegain of functionin vivoinsightmembermotor learningmutantnovelpolyglutaminepromoterresearch studytranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this project is to determine the role of capicua (Cic) in spinocerebellar ataxia type 1 (SCA1), a neurodegenerative disease caused by a polyglutamine expansion in Ataxin-1 (Atx-1). Cic is a transcriptional represser in Drosophila and preliminary results show that Cic interacts with Atx-1, co-localizes to Purkinje neurons that degenerate in SCA1, and its level is reduced in Atx-1-null mice. I will first analyze the expression of Cic during development in wild-type and Atx-1-null mice. I will generate and characterize Cic- null mice (Cic-/-) to determine the normal role of Cic in vivo and to determine its role in the normal function of Atx-1 (when crossed to Atx-1-null mice). Cic-null mice will be crossed to a knock-in model of SCA1 to determine whether and how Cic affects SCA1 pathogenesis. Given Cic's role as a transcriptional represser, I will investigate gene expression changes by microarray analysis in Cic and Cic-/- mice. Changes in Cic mutants will be compared to those of Atx-1-null and SCA1 knock-in mice (currently being performed by other laboratory members) to pinpoint those changes most relevant to SCA1 and Atx-1 function. This project will establish the role of Cic in mammals and in the normal function of Atx-1 and in SCA1 pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel genetic modifiers of C9orf72 and Tau toxicity
-
批准号:10084641
-
项目类别:
-
资助金额:$403.72万
-
财政年份:2019
-
负责人:John David Fryer
-
依托单位:
Functions of human and mouse Trem2 in vivo
-
批准号:9248837
-
项目类别:
-
资助金额:$19.56万
-
财政年份:2016
-
负责人:John David Fryer
-
依托单位:
Development and characterization of a novel Clusterin mouse model
-
批准号:9065478
-
项目类别:
-
资助金额:$7.83万
-
财政年份:2015
-
负责人:John David Fryer
-
依托单位:
The role of Clusterin in cerebral amyloid angiopathy
-
批准号:9765415
-
项目类别:
-
资助金额:$34.23万
-
财政年份:2015
-
负责人:John David Fryer
-
依托单位:
The role of Clusterin in cerebral amyloid angiopathy
-
批准号:9147489
-
项目类别:
-
资助金额:$34.23万
-
财政年份:2015
-
负责人:John David Fryer
-
依托单位:
Project 1
-
批准号:10415047
-
项目类别:
-
资助金额:$38.91万
-
财政年份:2014
-
负责人:John David Fryer
-
依托单位:
Project 1
-
批准号:10582728
-
项目类别:
-
资助金额:$42.26万
-
财政年份:2014
-
负责人:John David Fryer
-
依托单位:
Understanding the Mechanisms of TDP-43 Function
-
批准号:8507420
-
项目类别:
-
资助金额:$19.56万
-
财政年份:2013
-
负责人:John David Fryer
-
依托单位:
Understanding the Mechanisms of TDP-43 Function
-
批准号:8613510
-
项目类别:
-
资助金额:$23.24万
-
财政年份:2013
-
负责人:John David Fryer
-
依托单位:
The role of capicua in spinocerebellar ataxia type 1
-
批准号:7113397
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2006
-
负责人:John David Fryer
-
依托单位:
The role of capicua in spinocerebellar ataxia type 1
-
批准号:7450898
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2006
-
负责人:John David Fryer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: